Tagged with M

Opinion Michael Jewell, partner and head of healthcare & life sciences at Cavendish Corporate Finance looks back at the key trends across pharma industry funding in 2019 and gives his perspective on how 2020 will look.   As we approach the end of 2019, it’s a good time to look back…

Consulting PharMaCon is a marketing, communications and advertising agency specialized in the pharmaceutical and healthcare industry for the Latin American and Hispanic US market. CEO and founder, Ivelisse Casillas, explains the advantages of being a pharma and healthcare-focused company, and their strategy to conquer the US Hispanic market.   One of…

China Juergen Kurz takes us through HEUFT’s unique technology that is revolutionizing the quality of packaging in the pharmaceutical industry in a country, China, where quality compliance is now an issue.    Unlike big companies that seek to grow by acquiring small innovative companies, HEUFT grows organically.     Juergen, could…

GSK In conversation at the FT Global Pharmaceutical and Biotechnology Conference in London,* an energetic Emma Walmsley discussed the strategic and cultural shifts she has implemented in her two and a half years as CEO of iconic British firm GSK, the increasingly important intersection between technology and pharma, and countering the…

Merck Since we last met with Paolo Carli in 2013, he has been given greater responsibilities within Merck and is now Head of Middle East, Africa, Turkey, Russia, and CIS countries for the healthcare business. Paolo discusses the logic behind being assigned such a vast region to manage, Merck’s strategy for…

UAE Ana Raposo, country director for Gulf Countries at Janssen discusses her role, the main similarities and differences between the various markets throughout the Gulf, mental health, and corporate social responsibility (CSR) initiatives in the region.   The Gulf markets are very open to innovation and eager to bring the most…

Hungary Júlia Lipovecz, director of Swisscham Hungary, shares insights into the association and its activities to promote Swiss foreign investment in Hungary, the importance of local collaboration, and how its members perceive the Hungarian economic landscape.   Even though Switzerland is small in stature, the Chamber represents some of the largest…

Puerto Rico Edwards Lifesciences has been manufacturing catheters in Añasco, Puerto Rico, since 1972. Manuel Palma, general manager, explains the importance of the Añasco plant for Edwards’ global supply chain, and his modernization and vertical integration strategy to position the site as a centre of excellence for materials science and machine &…

China China’s new Amended Drug Administration Law is being enacted to strengthen and streamline its regulation of the pharmaceutical industry. The amended law seeks to address prominent problems in the pharmaceutical industry, such as counterfeit drugs, substandard drugs and high drug prices. Fangda Partners’ Josh Shin elaborates on China’s market authorization…

UAE The UAE pharma market is projected to grow over 80 percent by 2027, in part due to a growing demand for the treatment of lifestyle diseases and expansion of comprehensive health insurance.  Made with Visme Presentation Maker     Pharmaceutical imports into the UAE come from 72 countries. 80 percent…

UAE The UAE ranks as a world leader in rapid drug approvals with its fast-track registration system that accelerates the process and eliminates long waiting times for innovative and orphan drugs.   If you bring innovation, the [UAE] government will support you on all levels Georg Schroeckenfuchs, Novartis In January 2018…

Collaboration With sustainable development goals in mind, the global umbrella pharmaceutical association IFPMA has recently launched a platform that fosters collaboration with the aim of tackling problems related to health and equality through partnerships between biopharma companies, governments, academia and other local institutions.    Effective partnerships will help our innovations to…